These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25042198)

  • 1. Time-dependent effects of hydrophobic amine-containing drugs on lysosome structure and biogenesis in cultured human fibroblasts.
    Logan R; Kong AC; Krise JP
    J Pharm Sci; 2014 Oct; 103(10):3287-96. PubMed ID: 25042198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amine-containing molecules and the induction of an expanded lysosomal volume phenotype: a structure-activity relationship study.
    Logan R; Kong AC; Axcell E; Krise JP
    J Pharm Sci; 2014 May; 103(5):1572-80. PubMed ID: 24647827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.
    Funk RS; Krise JP
    Mol Pharm; 2012 May; 9(5):1384-95. PubMed ID: 22449202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes.
    Logan R; Kong A; Krise JP
    J Pharm Sci; 2013 Nov; 102(11):4173-80. PubMed ID: 23970383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications.
    Logan R; Funk RS; Axcell E; Krise JP
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):943-58. PubMed ID: 22616667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of lysosomotropic compounds based on the distribution and size of lysosomes.
    Seo I; Jha BK; Lim JG; Suh SI; Suh MH; Baek WK
    Biochem Biophys Res Commun; 2014 Jul; 450(1):189-94. PubMed ID: 24878535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications.
    Kaufmann AM; Krise JP
    J Pharm Sci; 2007 Apr; 96(4):729-46. PubMed ID: 17117426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal Biogenesis and Implications for Hydroxychloroquine Disposition.
    Collins KP; Witta S; Coy JW; Pang Y; Gustafson DL
    J Pharmacol Exp Ther; 2021 Feb; 376(2):294-305. PubMed ID: 33172973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis.
    Zhitomirsky B; Assaraf YG
    Oncotarget; 2017 Jul; 8(28):45117-45132. PubMed ID: 28187461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of amine accumulation in, and egress from, lysosomes.
    Goldman SD; Funk RS; Rajewski RA; Krise JP
    Bioanalysis; 2009 Nov; 1(8):1445-59. PubMed ID: 21083094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).
    Kazmi F; Hensley T; Pope C; Funk RS; Loewen GJ; Buckley DB; Parkinson A
    Drug Metab Dispos; 2013 Apr; 41(4):897-905. PubMed ID: 23378628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for lysosomotropic action of desipramine in cultured human fibroblasts.
    Honegger UE; Roscher AA; Wiesmann UN
    J Pharmacol Exp Ther; 1983 May; 225(2):436-41. PubMed ID: 6221090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99.
    Lemieux B; Percival MD; Falgueyret JP
    Anal Biochem; 2004 Apr; 327(2):247-51. PubMed ID: 15051542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal biogenesis in lysosomal storage disorders.
    Karageorgos LE; Isaac EL; Brooks DA; Ravenscroft EM; Davey R; Hopwood JJ; Meikle PJ
    Exp Cell Res; 1997 Jul; 234(1):85-97. PubMed ID: 9223373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomotropic properties of weakly basic anticancer agents promote cancer cell selectivity in vitro.
    Ndolo RA; Luan Y; Duan S; Forrest ML; Krise JP
    PLoS One; 2012; 7(11):e49366. PubMed ID: 23145164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased lysosomal biogenesis in activated microglia and exacerbated neuronal damage after traumatic brain injury in progranulin-deficient mice.
    Tanaka Y; Matsuwaki T; Yamanouchi K; Nishihara M
    Neuroscience; 2013 Oct; 250():8-19. PubMed ID: 23830905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
    Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M
    Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of lipophilicity and lysosomal accumulation on tissue distribution kinetics of basic drugs: a physiologically based pharmacokinetic model.
    Yokogawa K; Ishizaki J; Ohkuma S; Miyamoto K
    Methods Find Exp Clin Pharmacol; 2002 Mar; 24(2):81-93. PubMed ID: 12040887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system.
    Kornhuber J; Henkel AW; Groemer TW; Städtler S; Welzel O; Tripal P; Rotter A; Bleich S; Trapp S
    J Cell Physiol; 2010 Jul; 224(1):152-64. PubMed ID: 20301195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucosylceramide accumulation is not confined to the lysosome in fibroblasts from patients with Gaucher disease.
    Fuller M; Rozaklis T; Lovejoy M; Zarrinkalam K; Hopwood JJ; Meikle PJ
    Mol Genet Metab; 2008 Apr; 93(4):437-43. PubMed ID: 18162427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.